International projects
Petrovax aims at building up its international partnership and export potential. To implement its innovative strategy, the company cooperates with leading research institutes, Russian and international partners for the development of new products, technology transfer, and full-cycle manufacturing localization. Petrovax has adequate experience in implementing international projects associated with full-cycle manufacturing technology transfer as well as immunobiologicals quality control, and quality assurance.

International projects


In partnership with Abbott (former Solvay Pharma), Petrovax successfully completed the construction of an up-to-date pharmaceutical complex to develop and manufacture immunobiological products in Moscow region.


Petrovax, jointly with Pfizer, delivered a localization project to implement a full-cycle manufacturing, quality control, and quality assurance technology for a 13-valent pneumococcal conjugate vaccine.

Since 2014, this vaccine has been procured for the Russian national Immunization Schedule.


Petrovax implemented the first in the Russian history localization project to manufacture Russian original influenza vaccine Grippol® plus in Belarus under agreement with the Ministry of Health of Belarus, and RUE Belmedpreparaty.


Petrovax established a partnership with Boehringer Ingelheim to localize full-cycle manufacturing of the most advanced cardiovascular pharmaceuticals, and provide local products for the Russian public health.


Petrovax made a three-party agreement to localize Grippol® plus vaccine manufacture in Iran with Sobhan Recombinant Protein, and Arvin LTD (both Iran).

© Petrovax
The materials posted on the site are for informational purposes only and are not intended to advertise or promote the manufacturer or medications produced.